Lenz TherapeuticsLENZ 13F holders, Q1 2024 (March 31) 55 holders
2 famous investors
$22.30 avg. 13F price*
At the end of Q1 2024 , 55 institutions reported holding Lenz Therapeutics Inc. (LENZ) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($93.3M), Alpha Wave Global, LP ($80.7M) and EcoR1 Capital, LLC ($27.2M). 2 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
Company Lenz Therapeutics Inc.
CUSIP 52635N103
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2024 Institutions Total Value New Positions 57 $362.0M Exits 0 $0
Ownership 55 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Ra Capital Management, L.P. 1.19% New 4,178,823 $93.3M Alpha Wave Global, LP 24.52% New 3,612,211 $80.7M EcoR1 Capital, LLC 0.69% New 1,219,774 $27.2M Samsara Biocapital, LLC 4.18% New 1,208,473 $27.0M Sectoral Asset Management Inc. 9.38% New 1,068,675 $23.9M 72 Investment Holdings, LLC 33.88% New 1,017,751 $22.7M Point72 Asset Management 0.06% New 864,942 $19.3M RTW Investments, LP 0.28% New 863,389 $19.3M Tang Capital Management LLC 1.27% New 547,616 $12.2M BlackRock Inc. 0.00% New 241,016 $5.4M Vanguard Group Inc. 0.00% New 206,952 $4.6M Alyeska Investment Group, L.P. 0.03% New 199,602 $4.4M Jennison Associates LLC 0.00% New 134,740 $3.0M Board of Trustees of The Leland Stanford Junior University 0.20% New 100,438 $2.2M Geode Capital Management, LLC 0.00% New 88,218 $2.0M Ikarian Capital, LLC 0.52% New 85,000 $1.9M State Street Corp. 0.00% New 65,144 $1.5M Prosight Management, LP 0.40% New 65,000 $1.5M BML Capital Management, LLC 0.96% New 63,916 $1.4M Renaissance Technologies 0.00% New 46,866 $1.0M Debussy Capital Management LP 0.27% New 58,752 $924K Northern Trust Corp. 0.00% New 40,639 $907K Jacobs Levy Equity Management, Inc. 0.00% New 37,176 $830K Acuitas Investments, LLC 0.35% New 31,488 $703K Morgan Stanley 0.00% New 27,211 $608K Dimensional Fund Advisors LP 0.00% New 23,537 $526K Boothbay Fund Management, LLC 0.02% New 22,601 $505K Bridgeway Capital Management, LLC 0.01% New 21,920 $489K BNP Paribas Financial Markets 0.00% New 16,221 $362K Charles Schwab Investment Management Inc. 0.00% New 11,683 $261K Bank of New York Mellon Corp 0.00% New 11,181 $250K Cornercap Investment Counsel Inc. 0.03% New 9,350 $209K Barclays PLC 0.00% New 6,563 $147K Marquette Asset Management, LLC 0.02% New 5,865 $131K Rhumbline Advisers 0.00% New 4,598 $103K UBS Group AG 0.00% New 4,271 $95K Bank of America Corp. 0.00% New 3,927 $88K New York State Common Retirement Fund 0.00% New 3,490 $78K American International Group, Inc. 0.00% New 1,973 $44K JPMorgan Chase & Co. 0.00% New 1,682 $38K FMR LLC 0.00% New 1,373 $31K Wells Fargo & Company 0.00% New 1,359 $30K Qube Research & Technologies Ltd 0.00% New 982 $22K Citigroup Inc. 0.00% New 750 $17K Nisa Investment Advisors, LLC 0.00% New 644 $14K Group One Trading LLC 0.00% New 571 $13K California State Teachers Retirement System 0.00% New 454 $10K Tower Research Capital LLC (TRC) 0.00% New 451 $10K Legal & General Group Plc 0.00% New 382 $9K Ameritas Investment Partners, Inc. 0.00% New 331 $7K Lazard Asset Management LLC 0.00% New 288 $6K Amalgamated Bank 0.00% New 135 $3K Royal Bank of Canada 0.00% New 93 $2K Federation des caisses Desjardins du Quebec 0.00% New 28 $625 Osaic Holdings, Inc. 0.00% New 2 $45
"% of holder's portfolio" is LENZ's weight in each manager's 13F, not the share of Lenz Therapeutics Inc. the manager owns.